| Catalog Number | KRP312 |
| Alias | 白血病抑制因子受体, Leukemia inhibitory factor receptor , LIF receptor, LIF-R, CD antigen CD118, Leukemia inhibitory factor receptor, LIF receptor, |
| Size | 20ug, 50ug, 100ug, 200ug, 1mg |
| Product Description | Human LIFR(1-833 aa) |
| Molecular Name | LIFR |
| Product Introduction | 白血病抑制因子受体通过与内皮素转换酶结合，参与血管收缩调节。。 |
| Molecular Weight | 110-140 kDa |
| Expression System | HEK293F Cells |
| Species | Human |
| Concentration | 联系销售经理获得最新批次的浓度 |
| Purity | ≥95% |
| Purification | Affinity Purification |
| Uniprot ID | P42702-1 |
| Storage Condition | Store the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -20℃. Avoid repeated freeze-thaw cycles. |
| Formulation | Supplied in PBS |
| Shipping Condition | This product is shipped on ice packs or dry ice. |
| Background | Signal-transducing molecule. May have a common pathway with IL6ST. The soluble form inhibits the biological activity of LIF by blocking its binding to receptors on target cells. |
| Endotoxin | < 0.1 EU per ug |
| Biological Activity | Measured by its ability to inhibit LIF-dependent proliferation of TF‑1 human erythroleukemic cells. The ED50 forthis effect is typically 1-6 μg/mL in the presence of 0.3 ng/mL of recombinant human LIF |
| Product Declaration | 该产品仅供科研使用，不可直接用于人体或注射。 |
销售微信
官方公众号
0
